Drug · DIN 02528142
LETYBO
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 8, 2024; first marketed June 20, 2023.
- Drug Identification Number (DIN)
- 02528142
- Company (DIN owner)
- Hugel Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Botulinum toxin M03AX01
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LETIBOTULINUMTOXINA | 100 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2024: NOC 34356New Drug Submission (NDS) · Administrative - Manufacturer name change
- June 14, 2022: NOC 28398New Drug Submission (NDS)
Other DINs named LETYBO
- DIN 02528134 · Approved